Anat Cagan-Boehm
Ramat Aviv, TA 69978, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative Expedited Regulatory Programs of U.S Food & Drug Administration and Project Orbis Partners.
Journal: Therapeutic innovation & regulatory science
Published: November 09, 2022
ApoE4 Exacerbates Hippocampal Pathology Following Acute Brain Penetration Injury in Female Mice.
Journal: Journal of molecular neuroscience : MN
Published: April 28, 2019
The effects of apolipoprotein E genotype, α-synuclein deficiency, and sex on brain synaptic and Alzheimer's disease-related pathology.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: November 22, 2017
ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.
Journal: Journal of Alzheimer's disease : JAD
Published: August 29, 2016
Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.
Journal: PloS one
Published: August 15, 2016
Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
Journal: Journal of Alzheimer's disease : JAD
Published: July 04, 2016
Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: May 23, 2014
Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.
Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.
Journal: Current Alzheimer research
Published: August 29, 2013
Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice.
Journal: Neuro-degenerative diseases
Published: May 13, 2013
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
Journal: Molecular neurodegeneration
Published: June 19, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026